DongKookPharmaceuticalCo.,Ltd.
KOSDAQ
₩19,850.00
+1.17%
Delayed · cached 15 min
Fair value analysis
086450
DongKookPharmaceuticalCo.,Ltd.
₩19,850.00
Close used for this calculation
₩18,960.95Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
56/100
Quality radar
Consensus fair value
₩18,960.95
Near FV▼ -4.5% against the close used
Model range ₩3,801.53 – ₩32,000.24
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩3,801.53Fair value₩18,960.95Bull₩32,000.24
FairClose
52-week traded range
52W low ₩17,040.0052W high ₩22,250.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
DongKookPharmaceuticalCo.,Ltd. closed at ₩19,850.00, 4.7% above the consensus fair value of ₩18,960.95 drawn from 10 valuation models.
Financial DNA score 56/100 — Good. P/E of 13.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩7,718.67
-61.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=3.8%, r=10%, tg=3%, n=10yr
Graham Number
₩22,179.93
+11.7%
√(22.5 × EPS × BVPS)
EPS=1487, BVPS=14703.7
Graham Formula
₩32,000.24
+61.2%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=3.8%, FD=3.3%
P/E Fair Value
₩29,740.00
+49.8%
EPS × 20x (sector P/E)
EPS=1487, Sector P/E=20x
Peter Lynch (PEG)
₩5,680.34
-71.4%
EPS × Growth% (PEG = 1 is fair)
EPS=1487, g=3.8%
EV/EBITDA
₩23,128.83
+16.5%
(EBITDA × 11.9x − Net Debt) ÷ Shares
EBITDA=96.55B
Dividend Discount (DDM)
₩3,801.53
-80.8%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=226.29, r=10%, g=3.8%
Book Value (P/B)
₩14,584.74
-26.5%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=14703.7, ROE=10%, g=3.8%, r=10%
Reverse DCF
₩19,850.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 1.7% | Historical: 3.8%
Margin of Safety
₩17,182.28
-13.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=22909.71, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.